Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

RECORDATI RARE

  • FDA Approval
  • Sept. 17, 2024, 18:28 UTC
  • 53
  • 0 comments

FDA approve SUCCIMER

Comment Full text

CUMBERLAND

  • FDA Approval
  • Sept. 17, 2024, 18:28 UTC
  • 46
  • 0 comments

FDA approve GRANISETRON

Comment Full text

BAUSCH

  • FDA Approval
  • Sept. 17, 2024, 18:28 UTC
  • 51
  • 0 comments

FDA approve IMIQUIMOD

Comment Full text

THEA PHARMA

  • FDA Approval
  • Sept. 17, 2024, 08:46 UTC
  • 46
  • 0 comments

FDA approve LATANOPROST

Comment Full text

ZYDUS PHARMS

  • FDA Approval
  • Sept. 17, 2024, 08:46 UTC
  • 50
  • 0 comments

FDA approve LANSOPRAZOLE

Comment Full text

CHIA TAI TIANQING

  • FDA Approval
  • Sept. 17, 2024, 08:46 UTC
  • 49
  • 0 comments

FDA approve FOSAPREPITANT DIMEGLUMINE

Comment Full text

HIKMA

  • FDA Approval
  • Sept. 17, 2024, 08:46 UTC
  • 43
  • 0 comments

FDA approve ERLOTINIB HYDROCHLORIDE

Comment Full text

SOMERSET THERAPS LLC

  • FDA Approval
  • Sept. 17, 2024, 08:46 UTC
  • 45
  • 0 comments

FDA approve PROCHLORPERAZINE EDISYLATE

Comment Full text

STRIDES PHARMA

  • FDA Approval
  • Sept. 17, 2024, 08:46 UTC
  • 47
  • 0 comments

FDA approve FLUOXETINE HYDROCHLORIDE

Comment Full text

MSN

  • FDA Approval
  • Sept. 17, 2024, 08:46 UTC
  • 47
  • 0 comments

FDA approve NELARABINE

Comment Full text
  • Previous
  • 353
  • 354
  • 355
  • 356
  • 357
  • Next

Search

News categories

  • Technical Exchange News(12380)
  • Event(6229)
  • SEC News(274032)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(158463)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin